Document is current

Any future updates will be listed below

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

Crossref DOI link: https://doi.org/10.1007/s11060-017-2601-y

Published Online: 2017-08-28

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark